Biogen Halts Studies of Closely Watched Alzheimer's Drug, a Blow to Hopes for New Treatment

The last Posts from Scientific American

• Can a Pill Really Help You Live Longer?
• 4/20 Traffic Accidents Claim Curbed
• Hyena Society Stability Has Last Laugh
• Experimental Gene Therapy Frees "Bubble-boy" Babies from a Life of Isolation
• How Do I Know If My Tap Water Is Safe?
• Scientists Uncover California's Hidden Earthquakes
• It's A Match: Satellite and Ground Measurements Agree on Warming
• Big Data Has Transformed Agriculture.In Some Places, Anyway
• How We Roll: Study Shows We're More Lone Wolves than Team Players
• How Old Are Saturn's Rings? The Debate Rages On
• The Problem Isn't Sharing Misinformation Online; It's Believing It
• Liver Illness Strikes Latino Children Like a "Silent Tsunami"
• The Best of the Quantum Shorts Film Festival
• Pig Experiment Challenges Assumptions around Brain Damage in People
• Part-revived Pig Brains Raise Slew of Ethical Quandaries
• Watch Now: Einstein's Scientific Revolution and the Limits of Quantum Theory
• How France Can Rebuild Notre Dame
• To Find Earth-Threatening Comets and Asteroids, Think Small
• Stanford Clears Three Faculty Members of "CRISPR Babies" Involvement
• 'Oumuamua-like Objects Might Supercharge Planet Formation